BDNF and depressive symptom measurement: This inhibition shifts microglia from a pro-inflammatory state to a more neuroprotective phenotype and leads to increased BDNF synthesis, reduced synaptic pruning, and decreased neuronal apoptosis, ultimately promoting neuroprotection and alleviating depression-like behaviors.